Clinical Trial Update: A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

View source ↗

Summary

A Mayo Clinic trial update on isolating and testing circulating tumor cells using the ClearCell FX EP+ System in lung cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Cancer
• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Lung Cancer, Lung Neoplasms | Status: COMPLETED